FDA
approval
· 2025-06-13
FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
Summary
The FDA notes a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., seeking a regulatory change to Clozaril's labeling …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLOZARIL (CLOZAPINE)